Mass production of COVID-19 vaccine by September

62

New Delhi: A British Pharmaceutical Company has announced that it will undertake mass production of the coronavirus vaccine by September.

UK is one of the worst affected countries in the world.

Reports said AstraZeneca, the official partner for the coronavirus vaccine candidate from Oxford, will undertake production and marketing of the vaccine which will began by September.

The vaccine is under the human trials phase, reports said. The company hopes to have millions of doses ready in the next few months.

The company has signed a deal with the UK to produce 100 million doses. It is expected to produce 2 billion doses worldwide by mid-2021.

In the initial phase of testing, the vaccine was tested on healthy volunteers of age 18 to 55.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.